Navigation Links
K-V Pharmaceutical Company Announces $200 Million Private Debt Offering
Date:3/1/2011

ST. LOUIS, March 1, 2011 /PRNewswire/ -- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company") announced today that it intends to offer $200 million of senior secured notes due 2015 (the "Notes") in a private placement, subject to market conditions.

The Notes will be offered only to accredited investors pursuant to Regulation D under the Securities Act of 1933, as amended (the "Securities Act").  The Notes have not been registered under the Securities Act or any state or other securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements of the Securities Act and applicable state securities laws.

The Company intends to use the net proceeds from the offering of the Notes to repay in full the Company's outstanding obligations under its credit agreement with U.S. Healthcare I, L.L.C. and U.S. Healthcare II, L.L.C. (including the payment of related premiums) and terminate the related future loan commitments, to establish an escrow reserve for one year of interest payments on the Notes and for general corporate purposes.

This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any securities.

About K-V Pharmaceutical Company

K-V Pharmaceutical Company is a fully-integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded prescription pharmaceutical products. The Company markets its technology-distinguished products through Ther-Rx Corporation, its branded drug subsidiary.

For further information about K-V Pharmaceutical Company, please visit the Company's corporate Website at www.kvpharmaceutical.com.

Cautionary Note Regarding Forward-looking Statements

This press release contains various forward-looking statements within the mea
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
2. Jazz Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Results Conference Call on March 7
3. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
4. Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound
5. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
6. OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference
7. Omni Bio Pharmaceutical Intends to Expand Type 1 Diabetes Trial to 50 Patients
8. Endo Pharmaceuticals Raises 2011 Financial Guidance and Reports Strong Fourth Quarter 2010 Financial Results
9. MAP Pharmaceuticals to Present Data on LEVADEX™ at the 63rd Annual Meeting of the American Academy of Neurology
10. Savient Pharmaceuticals Announces U.S. Launch of KRYSTEXXA™; Reports Fourth Quarter and Year-End 2010 Financial Results
11. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Vernak, RPh, of Vernak Farms Pharmacy in ... George Roentsch Scholarship by the Professional Compounding Centers of ... Houston during PCCA,s International Seminar, held October ... independent pharmacist and PCCA member who embodies the innovative ... well-known pharmacist in the compounding community. ...
(Date:10/22/2014)... , Oct. 22, 2014 AVACEN Medical ... device received 510 (k) OTC clearance by the U.S. ... 100 to be marketed over the Internet for: ... muscle spasms; and minor strains and sprains . ... The AVACEN 100 (MSRP $2495) is a sophisticated medical ...
(Date:10/22/2014)... , October 22, 2014 ... ), a clinical-stage pharmaceutical company focused on the ... positive top-line clinical results from its Phase IIa ... insulin capsules, to treat type 1 diabetes. The trial ... under a U.S. Food and Drug ...
Breaking Medicine Technology:PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4
... Pharmaceuticals Inc. today announced an additional $7.5 million investment by ... Preferred Stock financing is now closed with a total of ... in early February, 2011.  Jim Scopa from MPM will join ... the proceeds to advance the clinical development of CTS-1027, a ...
... SEATTLE, April 12, 2011 The Allen Institute for ... genomically comprehensive human brain map, a previously unthinkable feat ... years of rigorous studies and documentation.  The unprecedented mappings ... an online public resource developed to advance the Institute,s ...
Cached Medicine Technology:Allen Institute for Brain Science Announces First Comprehensive Gene Map of the Human Brain 2Allen Institute for Brain Science Announces First Comprehensive Gene Map of the Human Brain 3Allen Institute for Brain Science Announces First Comprehensive Gene Map of the Human Brain 4
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... may lead to increased blood pressure, according to a new ... in blood pressure for young adult women or for teenagers, ... drank lightly or moderately, their risk of high blood pressure ... parallels studies in older adult men and women," said lead ...
(Date:10/22/2014)... News) -- Measures taken by Firestone officials at the ... have limited the spread of the disease there and ... Natural Rubber Co. provides health services to about 80,000 ... populated communities. Between Aug. 1 and Sept. 23, ... those 80,000 people. That incidence rate of 0.09 percent ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... cameraman who was diagnosed with Ebola while working for NBC ... and can leave the special isolation unit at Nebraska Medical Center ... weeks, the hospital said Tuesday. A blood test confirmed by ... Mukpo, 33, can head home to Providence, R.I., NBC News ...
(Date:10/20/2014)... With a mere 19 days to November ... brief fundraising stop at the  Law Offices of ... a debate last night with his opponent Gov. Rick ... first seven minutes because Crist had an electric fan ... in one word: "weird." , Before touching on his ...
(Date:10/20/2014)... The Advocator Group, LLC is ... Foundation for Suicide Prevention’s (AFSP) Out of the Darkness ... organization that hosts hundreds of community walks throughout the ... used to help understand and prevent suicide through not ... well. , The Advocator Group shares this passion ...
Breaking Medicine News(10 mins):Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3
... care at community health clinics especially women ... cardiologist than those who receive primary care at hospitals, ... the American Heart Association . , Researchers from the ... Medical School reviewed the electronic medical records of 9,761 ...
... April 27 Robert J. Gould, a behavioral ... nation,s most successful social marketing campaigns, has been ... by Partnership,s board of directors was announced today ... board."Rob,s unique combination of behavioral science expertise, proven ...
... a worrisome rise in childhood obesity, Florida school districts ... but there is little research available to determine if ... a $2.2 million grant from the National Institutes of ... a Florida State University College of Medicine researcher will ...
... today that, working with the UN Refugee Agency (UNHCR), it will send ... African countries. , ... Washington, D.C. (Vocus) April 27, 2009 -- The ... Refugee Agency (UNHCR), it will send over 346,000 life-saving bed nets to ...
... April 27 50,000 hand addressed letters were sent to ... Notre Dame officials, urging ND Grads to fight ... sent 50,000 letters to Alumni from ,88 and back. (Older ... post cards are designed to be sent to Vatican and ...
... Company (Nasdaq: STAA ) today announced that it will release financial ... May 5, 2009 after ... host a conference call and webcast on Tuesday, ... 1:30 p.m. Pacific to discuss the Company,s first quarter results ...
Cached Medicine News:Health News:Patients at community health clinics less likely to be referred to cardiologist 2Health News:Patients at community health clinics less likely to be referred to cardiologist 3Health News:Robert J. Gould Named President at Partnership for Prevention 2Health News:FSU researcher wins $2.2 million grant to study childhood obesity 2Health News:FSU researcher wins $2.2 million grant to study childhood obesity 3Health News:UN Foundation to Help Protect More than a Million Refugees from Malaria in Africa 2Health News:50,000 Letters Sent to Notre Dame Alumni Re: Obama; In Letter, Bishop Gracida Urged Former U.S. Ambassador to the Vatican Mary Ann Glendon to Refuse Award 2Health News:STAAR Surgical Announces First Quarter 2009 Earnings Release Date and Conference Call 2
Advanced operating microscope with zoom and variable focus up to 500 mm....
PS Medical lumboperitoneal catheter systems are designed to divert CSF from the lumbar subarachnoid space to the peritoneal cavity, using simplified surgical techniques....
Micro Dissecting Curette, 5 1/2", Round....
10 overall length 4.5 from bend 250 mm. 90...
Medicine Products: